ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia.

Sharyn D Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.